Tellgen Corp operates in the Diagnostic substances sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Tellgen Corp with three other
companies in this sector in China:
BioSino Bio-technology and Science Inc
sales of 295.13 million Chinese Renmimbi [US$43.58 million]
Guangdong Hybribio Biotech Co Ltd
(479.09 million Chinese Renmimbi [US$70.74 million]
of which 97%
was Monitoring Instrument), and
Getein Biotech Inc
(488.58 million Chinese Renmimbi [US$72.14 million]
of which 99%
was In-vitro diagnostics).